Company Filing History:
Years Active: 2018-2025
Title: Innovations by Hiroyuki Abe in MRI Technology
Introduction
Hiroyuki Abe is an accomplished inventor based in Chicago, IL, with a focus on advancements in magnetic resonance imaging (MRI) technology. He holds 2 patents that contribute significantly to the field of medical imaging and tumor characterization.
Latest Patents
One of his latest patents is titled "Characterization of lesions via determination of vascular metrics using MRI data." This patent discloses methods to non-invasively characterize tumors or lesions by analyzing MRI data. The techniques involve ultrafast dynamic contrast-enhanced MRI (DCE-MRI) and diffusion-weighted MRI (DW-MRI) scans. By determining vasculature metrics, the patent allows for the assessment of tumor-associated blood flow velocity and interstitial pressure, aiding in the characterization of malignancy and treatment response.
Another notable patent is "Contrast medium uptake time computation using magnetic resonance imaging." This invention involves a computing device that determines the uptake time of a contrast medium using MRI data. The process includes reading image data from an MRI machine and identifying baseline artery locations. The invention calculates the time-of-arrival (TOA) of the contrast medium, which assists in lesion identification for patients.
Career Highlights
Hiroyuki Abe has worked with prestigious institutions such as the University of Chicago and the University of Texas System. His contributions to MRI technology have been recognized in various medical and scientific communities.
Collaborations
Some of his notable coworkers include Aytekin Oto and Gregory S. Karczmar, who have collaborated with him on various projects related to MRI technology and its applications in medical diagnostics.
Conclusion
Hiroyuki Abe's innovations in MRI technology demonstrate his commitment to enhancing medical imaging and improving patient outcomes. His patents reflect significant advancements in the characterization of tumors and lesions, showcasing the potential of MRI in clinical applications.